A Bi-Specific T Cell-Engaging Antibody Shows Potent Activity, Specificity, and Tumor Microenvironment Remodeling in Experimental Syngeneic and Genetically Engineered Models of GBM
Microfluidic-based immunohistochemistry combined with next-generation sequencing on diagnostic tissue sections for detection of tumoral BRAF V600E mutation
